Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands

Design, syntheses and structure-activity relationships of piperazine privileged structures containing MC4R agonist compounds 6 were described. The most potent derivatives were low nM MC4R selective full agonists. Several compounds from the series had modest pharmacokinetic properties.